My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2025-126D
CBCC
>
Official Documents
>
2020's
>
2025
>
2025-126D
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/18/2025 10:43:54 AM
Creation date
9/8/2025 1:42:16 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
06/03/2025
Control Number
2025-126D
Agenda Item Number
13.D.1.
Entity Name
Rightway Healthcare, Inc.
Subject
Pharmacy Benefit Management Services Agreement
Document Relationships
2025-126
(Cover Page)
Path:
\Official Documents\2020's\2025
2025-126A
(Cover Page)
Path:
\Official Documents\2020's\2025
2025-126B
(Cover Page)
Path:
\Official Documents\2020's\2025
2025-126C
(Cover Page)
Path:
\Official Documents\2020's\2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
179
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Docusign Envelope ID: 921 F7A24-D5CE-4BCC-9F3C-5E7844661266 <br />21535580400120 <br />Talzenna CAPS 1 MG <br />13.00% <br />21535750000120 <br />Gavreto CAPS 100 MG <br />15.75% <br />21535779000140 <br />Memo CAPS 80 MG <br />15.50% <br />21535779000330 <br />Retevmo TABS 80 MG <br />13.00% <br />21535779000340 <br />Retevmo TABS 120 MG <br />13.00% <br />21535779000350 <br />Retevmo TABS 160 MG <br />13.00% <br />21536045100120 <br />Ninlaro CAPS 2.3 MG <br />13.00% <br />21536045100130 <br />Ninlaro CAPS 3 MG <br />13.00% <br />21536045100140 <br />Ninlaro CAPS 4 MG <br />13.00% <br />21537520200120 <br />Inrebic CAPS 100 MG <br />16.00% <br />21537540300320 <br />Ojjaara TABS 100 MG <br />15.50% <br />21537540300330 <br />Ojjaara TABS 150 MG <br />15.50% <br />21537540300340 <br />Ojjaara TABS 200 MG <br />15.50% <br />21537550100120 <br />Vonjo CAPS 100 MG <br />13.00% <br />21538030000120 <br />Copiktra CAPS 15 MG <br />15.80% <br />21538030000130 <br />Copiktra CAPS 25 MG <br />15.80% <br />21538040000320 <br />Zydelig TABS 100 MG <br />13.00% <br />21538040000330 <br />Zydelig TABS 150 MG <br />13.00% <br />21540050401820 <br />Adstiladrin SUSP 300000000000 VP/ML <br />13.00% <br />21600035202020 <br />Azedra Therapeutic SOLN 15 MCl/ML <br />13.00% <br />21600045202020 <br />Lutathera SOLN 370 MBQ/ML <br />13.00% <br />21600045802020 <br />Pluvicto SOLN 1000 MBQ/ML <br />13.00% <br />21600055002025 <br />Xofigo SOLN 30 MCCl/ML <br />16.00% <br />21650850101820 <br />Omisirge SUSP <br />13.00% <br />21651006101820 <br />Tecelra SUSP 10000000000 CELLS <br />13.00% <br />21651010101820 <br />Yescarta SUSP 200000000 CELLS <br />13.00% <br />21651020101810 <br />Tecartus SUSP 100000000 CELLS <br />13.00% <br />21651020101820 <br />Tecartus SUSP 200000000 CELLS <br />13.00% <br />21651025101820 <br />Carvykti SUSP 100000000 CELLS <br />13.00% <br />21651035401820 <br />Abecma SUSP 460000000 CELLS <br />13.00% <br />21651047001820 <br />Amtagvi SUSP 72000000000 CELLS <br />13.00% <br />21651050401820 <br />Breyanzi SUSP 70000000 CELLS/ML <br />13.00% <br />21651070001820 <br />Provenge SUSP 50000000 CELLS <br />13.00% <br />21651075001820 <br />Kymriah SUSP 250000000 CELLS <br />13.00% <br />21651075001830 <br />Kymriah SUSP 600000000 CELLS <br />13.00% <br />21700060702020 <br />Actimmune SOLN 100 MCG/0.5ML <br />15.50% <br />21703055652020 <br />Anktiva SOLN 400 MCG/0.4ML <br />13.00% <br />57 <br />This document is CONFIDENTIAL AND PROPRIETARY to RIGHTWAY Healthcare, Inc. and may not be reproduced, <br />transmitted, published, or disclosed to others without the prior written authorization of RIGHTWAY Healthcare, Inc. <br />
The URL can be used to link to this page
Your browser does not support the video tag.